|About Us||Patients, Families & Visitors||For Health Professionals||Careers||Research & Training||Ways to Give|
|Checkmate 649 Gastric-GEJ||
Dr. M. Vincent
A Randomized, Multicenter, Open-Label, Phase 3 Study of Nivolumab Plus Ipilimumab versus Oxaliplatin plus Fluoropyrimidine in Subjects with Previously Untreated Advanced or Metastatic gastric or Gastroesophageal Junction Cancer
Dr. Mark Vincent
A Phase III, Randomised, international trial comparing mFOLFIRINOX triplet chemotherapy to mFOLFOX for high-risk stage III colon cancer in adjuvant setting.
Dr. M. Sanatani
A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patients with High-Risk Stage II or Stage III Colon Cancer: A Randomized Controlled Trial (CHALLENGE)
|RTOG 1112 GI||
Dr. M. Lock
Randomized Phase III Study of Sorafenib versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma
Dr. S. Welch
A Phase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total
Dr. Stephen Welch
A Randomized Phase II Trial of Gemcitabine and Nab-Paclitaxel Vs. Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma.
Dr. Robert Dinniwell
"not yet open" Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma.
Dr. S. Welch
A Phase III Clinical Trial Evaluating TheraSphere in Patients with Metastatic Colorectal Carcinoma of the Liver who have Failed First Line Chemotherapy
This information is updated by the Clinical Research Unit